Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDTH > SEC Filings for MDTH > Form 10-Q on 10-Aug-2009All Recent SEC Filings

Show all filings for MEDCATH CORP | Request a Trial to NEW EDGAR Online Pro

Form 10-Q for MEDCATH CORP


10-Aug-2009

Quarterly Report


Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the interim unaudited consolidated financial statements and related notes included elsewhere in this report, as well as the audited consolidated financial statements and related notes thereto and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2008.
Overview
General. We are a healthcare provider focused primarily on providing high acuity services, predominantly the diagnosis and treatment of cardiovascular disease. We own and operate hospitals in partnership with physicians whom we believe have established reputations for clinical excellence. We have ownership interests in and operate nine hospitals, with a total of 755 licensed beds, of which 705 are staffed and available, and are located predominately in high growth markets in seven states: Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. We are currently in the process of developing a new hospital in Kingman, Arizona. We expect this hospital to open in late 2009 or early 2010. This hospital is designed to accommodate a total of 106 licensed beds and will initially open with 70 licensed beds. We completed our 79 bed expansion at Louisiana Medical Center and Heart Hospital during May 2009, with remaining capacity for an additional 40 beds at that hospital. We also have plans to expand our Bakersfield Heart Hospital by 72 inpatient beds and 16 emergency department beds that will diversify the services offered by that hospital.
In addition to our hospitals, we currently own and/or manage 19 cardiac diagnostic and therapeutic facilities. Twelve of these facilities are located at hospitals operated by other parties. These facilities offer invasive diagnostic and, in some cases, therapeutic procedures. The remaining seven facilities are not located at hospitals and offer only diagnostic procedures.
Revenue Sources by Division. The largest percentage of our net revenue is attributable to our Hospital Division. The following table sets forth the percentage contribution of each of our consolidating divisions to consolidated net revenue in the periods indicated below.

                           Three Months Ended June 30,         Nine Months Ended June 30,
  Division                   2009               2008             2009               2008
  Hospital                      95.0 %             94.4 %           95.0 %             94.2 %
  MedCath Partners               4.9 %              5.2 %            4.9 %              5.4 %
  Corporate and other            0.1 %              0.4 %            0.1 %              0.4 %

  Net Revenue                  100.0 %            100.0 %          100.0 %            100.0 %

Revenue Sources by Payor. We receive payments for our services rendered to patients from the Medicare and Medicaid programs, commercial insurers, health maintenance organizations and patients directly. Our net revenue is determined by a number of factors, including the payor mix, the number and nature of procedures performed and the rate of payment for the procedures. Since cardiovascular disease disproportionately affects those age 55 and older, the proportion of net revenue we derive from the Medicare program is higher than that of most general acute care hospitals. The following table sets forth the percentage of consolidated net revenue we earned by category of admitting payor in the periods indicated.

                                                   Three Months Ended June 30,                Nine Months Ended June 30,
Payor                                               2009                 2008                 2009                 2008
Medicare                                               49.7 %               51.2 %               51.9 %               52.0 %
Medicaid                                                1.9 %                2.8 %                3.0 %                3.1 %
Commercial and other, including self-pay               48.4 %               46.0 %               45.1 %               44.9 %

Total consolidated net revenue                        100.0 %              100.0 %              100.0 %              100.0 %

A significant portion of our net revenue is derived from federal and state governmental healthcare programs, including Medicare and Medicaid, and we expect the net revenue that we receive from the Medicare program as a percentage of total consolidated net revenue will remain significant in future periods. Our payor mix may fluctuate in future periods due to changes in reimbursement, market and industry trends with self-pay patients, and other similar factors.
The Medicare and Medicaid programs are subject to statutory and regulatory changes, retroactive and prospective rate adjustments, administrative rulings, court decisions, executive orders and freezes and funding reductions, all of which may significantly affect our business. In addition, reimbursement is generally subject to adjustment following audit by third party payors, including the fiscal intermediaries who administer the Medicare program, i.e. the CMS. Final determination of amounts due providers under the Medicare program often takes several years because of such audits, as well as resulting provider appeals and the application of technical reimbursement provisions. We believe that adequate provision has been made for any adjustments that might result from these programs; however, due to the complexity of laws and regulations governing the Medicare and Medicaid programs, the manner in which they are interpreted and the other complexities involved in estimating our net revenue, there is a possibility that recorded estimates will change by a material amount in the future.


Table of Contents

In 2005, CMS began using RACs to detect Medicare overpayments not identified through existing claims review mechanisms. The RAC program relies on private auditing firms to examine Medicare claims filed by healthcare providers. Fees to the RACs are paid on a contingency basis. The RAC program began as a demonstration project in 2005 in three states (New York, California and Florida) which was expanded into the three additional states of Arizona, Massachusetts and South Carolina in July 2007. No RAC audits, however, were initiated at our Arizona or California hospitals during the demonstration project. The program was made permanent by the Tax Relief and Health Care Act of 2006 enacted in December 2006. CMS announced in March 2008 the end of the demonstration project and the commencement of the permanent program by the expansion of the RAC program to additional states beginning in the summer and fall 2008 and its plans to have RACs in place in all 50 states by 2010.
RACs perform post-discharge audits of medical records to identify Medicare overpayments resulting from incorrect payment amounts, non-covered services, incorrectly coded services, and duplicate services. CMS has given RACs the authority to look back at claims up to three years old, provided that the claim was paid on or after October 1, 2007. Claims identified as overpayments will be subject to the Medicare appeals process.
Even though the Company believes the claims for reimbursement submitted to the Medicare program by the Company's facilities have been accurate, the Company is unable to reasonably estimate what the potential result of future RAC audits or other reimbursement matters could be. Results of Operations
Three Months Ended June 30, 2009 Compared to Three Months Ended June 30, 2008 Statement of Operations Data. The following table presents our results of operations in dollars and as a percentage of net revenue for the periods indicated:

                                                           Three Months Ended June 30,
                                                        (in thousands except percentages)
                                                                 Increase/Decrease                 % of Net Revenue
                             2009             2008               $               %               2009            2008
Net revenue                $ 150,904        $ 154,273        $  (3,369 )          (2.2 )%         100.0 %         100.0 %
Operating expenses:
Personnel expense             50,862           50,520              342             0.7 %           33.7 %          32.8 %
Medical supplies
expense                       44,995           42,757            2,238             5.2 %           29.8 %          27.7 %
Bad debt expense              12,547           10,235            2,312            22.6 %            8.3 %           6.6 %
Other operating
expenses                      31,441           29,555            1,886             6.4 %           20.8 %          19.2 %
Pre-opening expenses             754              149              605           406.0 %            0.5 %           0.1 %
Depreciation                   7,858            7,505              353             4.7 %            5.2 %           4.9 %
Amortization                     230              149               81            54.4 %            0.2 %           0.1 %
(Gain) loss on
disposal of property,
equipment and other
assets                           (26 )            225             (251 )         111.6 %           (0.0 )%          0.1 %

Income from
operations                     2,243           13,178          (10,935 )         (83.0 )%           1.5 %           8.5 %
Other income
(expenses):
Interest expense              (1,151 )         (3,862 )          2,711            70.2 %           (0.8 )%         (2.5 )%
Interest and other
income, net                       52              284             (232 )         (81.7 )%           0.0 %           0.2 %
Equity in net
earnings of
unconsolidated
affiliates                     2,265            2,636             (371 )         (14.1 )%           1.5 %           1.7 %

Income from
continuing operations
before minority
interest, income
taxes and
discontinued
operations                     3,409           12,236           (8,827 )         (72.1 )%           2.2 %           7.9 %
Minority interest
share of earnings of
consolidated
subsidiaries                  (2,287 )         (3,865 )          1,578            40.8 %           (1.5 )%         (2.5 )%

Income from
continuing operations
before income taxes
and discontinued
operations                     1,122            8,371           (7,249 )         (86.6 )%           0.7 %           5.4 %
Income tax expense               536            3,469           (2,933 )         (84.5 )%           0.3 %           2.2 %

Income from
continuing operations            586            4,902           (4,316 )         (88.0 )%           0.4 %           3.2 %
(Loss) income from
discontinued
operations, net of
taxes                            (90 )          6,870           (6,960 )        (101.3 )%          (0.1 )%          4.4 %

Net income                 $     496        $  11,772        $ (11,276 )         (95.8 )%           0.3 %           7.6 %


Table of Contents

                                                                       Three Months Ended June 30,
                                                                2009               2008%            Change
Selected Operating Data (a):
Number of hospitals                                                  7                  7
Licensed beds (b)                                                  588                449
Staffed and available beds (c)                                     542                449
Admissions (d)                                                   6,352              7,384            (14.0 )%
Adjusted admissions (e)                                         10,284             10,341             (0.6 )%
Patient days (f)                                                25,482             27,132             (6.1 )%
Adjusted patient days (g)                                       41,174             38,105              8.1 %
Average length of stay (days) (h)                                 4.01               3.67              9.3 %
Occupancy (i)                                                     51.7 %             66.4 %
Inpatient catheterization procedures (j)                         3,071              3,961            (22.5 )%
Inpatient surgical procedures (k)                                2,045              2,260             (9.5 )%
Hospital net revenue (in thousands except percentages)       $ 141,665          $ 144,676             (2.1 )%

(a) Selected operating data includes consolidated hospitals in operation as of the end of the period reported in continuing operations but does not include hospitals which are accounted for using the equity method or as discontinued operations in our consolidated financial statements.

(b) Licensed beds represent the number of beds for which the appropriate state agency licenses a facility regardless of whether the beds are actually available for patient use.

(c) Staffed and available beds represent the number of beds that are readily available for patient use at the end of the period.

(d) Admissions represent the number of patients admitted for inpatient treatment.

(e) Adjusted admissions is a general measure of combined inpatient and outpatient volume. We computed adjusted admissions by dividing gross patient revenue by gross inpatient revenue and then multiplying the quotient by admissions.

(f) Patient days represent the total number of days of care provided to inpatients.

(g) Adjusted patient days is a general measure of combined inpatient and outpatient volume. We computed adjusted patient days by dividing gross patient revenue by gross inpatient revenue and then multiplying the quotient by patient days.

(h) Average length of stay
(days) represents the average number of days inpatients stay in our hospitals.

(i) We computed occupancy by dividing patient days by the number of days in the period and then dividing the quotient by the number of staffed and available beds.

(j) Inpatient catheterization procedures represent the number of inpatients with a procedure performed in one of the hospitals' catheterization labs during the period.

(k) Inpatient surgical procedures represent the number of surgical procedures performed on inpatients during the period.

Net Revenue. Our consolidated net revenue decreased 2.2% or $3.4 million to $150.9 million for the third quarter of fiscal 2009 from $154.3 million for the third quarter of fiscal 2008. Hospital Division net revenue decreased 2.1%, or $3.0 million, for the third quarter of fiscal 2009 compared to the same period of fiscal 2008, in addition to declines in our MedCath Partners division and Corporate and other.
Over the past several quarters, our hospitals have experienced a shift in patient clinical setting from inpatient to outpatient as the result of advancement in medical technologies and at the direction of certain of our payors. Total inpatient net revenue was 66% of the Hospital Division's total net patient revenue for the third quarter of fiscal 2009 compared to approximately 74% for the third quarter of fiscal 2008.
Inpatient Hospital division net revenue decreased 13% in the third quarter of fiscal 2009 compared to the third quarter of fiscal 2008 and admissions declined 14% from 7,384 to 6,352. Inpatient net revenue declined for all of our core cardiovascular procedures with the exception of open heart procedures, which increased $0.9 million for the third quarter of fiscal 2009 compared to the third quarter of fiscal 2008. The overall decline in net patient revenue from our core cardiovascular procedures was partially offset by inpatient net revenue increases for new services performed at our hospitals such as digestive procedures.
Outpatient Hospital division net revenue increased 26% in the third quarter of fiscal 2009 compared to the third quarter of fiscal 2008 and outpatient cases increased 13.1% from 16,183 to 18,302. Outpatient net revenue increased for all service lines with the exception of angioplasty procedures.
Total net patient revenue related to drug eluting stent procedures and bare metal stent procedures, regardless of clinical setting, decreased $1.4 million, or 5.2%, for the third quarter of fiscal 2009 compared to the same quarter of fiscal 2008.


Table of Contents

Net revenue for the third quarter of fiscal 2008 included charity care deductions of $4.2 million compared to charity care deductions of $1.0 million for fiscal 2009. The reduction is the result of fewer patients applying and qualifying for charity discounts during the third quarter of fiscal 2009 compared to the same period of the prior year.
Net revenue for the third quarter of fiscal 2009 was reduced by $3.1 million as a result of a reduction in the estimated amount of Medicare Disproportionate Share Hospital ("DSH") payments certain hospitals are eligible for in prior periods. The primary method for a hospital to qualify for Medicare DSH reimbursement is based on a statutory formula that utilizes the percentage of inpatient days attributable to patients eligible for Medicaid, but not eligible for Medicare Part A, and a base formula called the Supplemental Security Income ("SSI") percentage, which is released annually by the CMS. Based on the updated SSI percentage provided by CMS during June, 2009, we determined that four hospitals that we previously determined were eligible for DSH payments in fiscal 2007 and fiscal 2008 would either no longer be eligible for such payments or would be eligible for less payment than initially estimated.
Personnel expense. Personnel expense increased 0.7% to $50.9 million for the third quarter of fiscal 2009 from $50.5 million for the third quarter of fiscal 2008. The $0.4 million increase in personnel expense was due primarily to annual merit increases and a corresponding increase in benefits offset by a $1.3 million reduction in stock compensation expense. Stock based compensation expense was $0.2 million for the third quarter of fiscal 2009 compared to $1.5 million for the third quarter of fiscal 2008. The stock based compensation expense for the third quarter of fiscal 2009 was recorded based on a vesting schedule related to the issuance of restricted shares to certain employees which vest over a three year period or vest 50% over a three year period and 50% over the same three year period if certain performance criteria are satisfied. The stock based compensation expense for the third quarter of fiscal 2008 was based on the issuance of stock options which vested immediately.
Medical supplies expense. Medical supplies expense increased 5.2% to $45.0 million for the third quarter of fiscal 2009 from $42.8 million for the third quarter of fiscal 2008. The $2.2 million increase in medical supplies is a result of a 4.1% increase in open heart cases, a 32.1% increase in musculoskeletal cases and a 42.6% increase in the usage of drug eluting stents offset by a 20.6% decrease in the usage of bare metal stents. In addition, our average length of stay increased 9.3%, which resulted in a 11.3% increase in non-chargeable supply expense.
Bad debt expense. Bad debt expense increased 22.6% to $12.5 million for the third quarter of fiscal 2009 from $10.2 million for the third quarter of fiscal 2008. As a percentage of net revenue, bad debt expense increased to 8.3% for the third quarter of fiscal 2009 as compared to 6.6% for the comparable period of fiscal 2008. Our total uncompensated care including charity care and bad debt expense was 9.5% of total net patient hospital revenue for the third quarter of fiscal 2009 compared to 9.6% of total net patient revenue for the third quarter of fiscal 2008. The total number of patients which applied and qualified for charity care reduced during third quarter of fiscal 2009 compared to the third quarter of fiscal 2008. We reported $3.2 million more charity deductions to net revenue during the third quarter of fiscal 2008 when compared to the third quarter of fiscal 2009.
Other operating expenses. Other operating expenses increased 6.4% to $31.4 million for the third quarter of fiscal 2009 from $29.6 million for the third quarter of fiscal 2008. The increase is attributable to the following:
• $1.1 million increase in professional fees associated with an internal assessment of certain controls and procedures completed during the quarter.

• $0.8 million increase in penalty expense for the anticipated settlement of regulatory claims at two of our hospitals related to the identification, return and self-reporting of $0.7 million in reimbursement for certain procedures performed at those hospitals in prior fiscal years.

• $0.4 million increase in severance payments.

The above increases were offset by a decrease in our medical malpractice insurance expense of $0.6 million for the third quarter of fiscal 2009 compared to the third quarter of fiscal 2008.
Interest expense. Interest expense decreased $2.7 million or 70.2% to $1.2 million for the third quarter of fiscal 2009 from $3.9 million for the third quarter of fiscal 2008. The $2.7 million decrease in interest expense is primarily attributable to the overall reduction in our outstanding debt, interest rates on our outstanding debt, and the capitalization of interest on our capital expansion projects. Capitalized interest was $0.8 million for the third quarter of fiscal 2009 compared to $0.4 million for the third quarter of fiscal 2008.
Interest and other income. Interest and other income decreased to $0.1 million for the third quarter of fiscal 2009 from $0.3 million for the third quarter of fiscal 2008. The decrease in interest and other income is a direct result of the approximately $77.9 million decrease in our cash and cash equivalent balance from June 30, 2008 to June 30, 2009, which resulted in a reduction in interest earned on cash balances.
Minority interest share of earnings of consolidated subsidiaries. Minority interest share of earnings of consolidated subsidiaries decreased to $2.3 million for the first three months of fiscal 2009 from $3.9 million for the comparable period of fiscal 2008. We expect our earnings allocated to minority interests to fluctuate in future periods as we either recognize disproportionate losses and/or recoveries thereof through disproportionate profit recognition. For a more complete discussion of our accounting for minority interests, including the basis for disproportionate allocation accounting, see Critical Accounting Policies in our Annual Report on Form 10-K for the fiscal year ended September 30, 2008.


Table of Contents

Income tax expense. Income tax expense was $0.5 million for the third quarter of fiscal 2009 compared to $3.5 million for the third quarter of fiscal 2008, which represents an effective tax rate of approximately 47.8% and 41.4% for the respective periods. The 47.8% rate for the third quarter of fiscal 2009 is the effective rate created due to permanent, non-recurring items during the reporting period. The income tax rate for the third quarter of fiscal 2008 was negatively impacted by the write-off goodwill based on the valuation of one of our hospitals we subsequently sold. The write-off of goodwill is a non-deductible tax expense in the period the write-off occurs.
(Loss) income from discontinued operations, net of taxes. (Loss) income from discontinued operations, net of taxes, reflects the results of Dayton Heart Hospital, Cape Cod Cardiology, and the Heart Hospital of Lafayette for the third quarter of fiscal 2009 and fiscal 2008. Income from discontinued operations decreased to a loss of $0.1 million, net of tax, for the third quarter of fiscal 2009 from income of $6.9 million, net of tax, for the comparable period of fiscal 2008. Loss from discontinued operations during the third quarter of fiscal 2009 related to continued payments of liabilities associated with the divested facilities, whereas the income from discontinued operations from same quarter of fiscal 2008 was related to operating income from Cape Cod Cardiology offset by losses at Dayton Heart Hospital. Nine months ended June 30, 2009 Compared to Nine Months Ended June 30, 2008 Statement of Operations Data. The following table presents our results of operations in dollars and as a percentage of net revenue for the periods indicated:

                                                            Nine Months Ended June 30,
                                                        (in thousands except percentages)
                                                                 Increase/Decrease                 % of Net Revenue
                             2009             2008               $               %               2009            2008
Net revenue                $ 462,874        $ 455,168        $   7,706             1.7 %          100.0 %         100.0 %
Operating expenses:
Personnel expense            153,644          150,060            3,584             2.4 %           33.2 %          33.0 %
Medical supplies
expense                      131,457          123,155            8,302             6.7 %           28.4 %          27.0 %
Bad debt expense              34,558           31,852            2,706             8.5 %            7.5 %           7.0 %
Other operating
expenses                      96,022           88,996            7,026             7.9 %           20.8 %          19.5 %
Pre-opening expenses           1,340              643              697           108.4 %            0.3 %           0.1 %
Depreciation                  23,258           22,535              723             3.2 %            5.0 %           5.0 %
Amortization                     589              411              178            43.3 %            0.1 %           0.1 %
Loss on disposal of
property, equipment
and other assets                 138              391             (253 )          64.7 %            0.0 %           0.1 %

Income from
operations                    21,868           37,125          (15,257 )         (41.1 )%           4.7 %           8.2 %
Other income
(expenses):
Interest expense              (5,339 )        (11,658 )          6,319            54.2 %           (1.1 )%         (2.6 )%
Loss on early
extinguishment of
debt                          (6,702 )              -           (6,702 )        (100.0 )%          (1.4 )%            -
Interest and other
income, net                      218            1,930           (1,712 )         (88.7 )%             -             0.4 %
Equity in net
earnings of
unconsolidated
affiliates                     7,044            6,842              202             3.0 %            1.5 %           1.5 %

Income from
continuing operations
before minority
interest, income
taxes and
discontinued
operations                    17,089           34,239          (17,150 )         (50.1 )%           3.7 %           7.5 %
Minority interest
share of earnings of
consolidated
subsidiaries                  (9,703 )        (12,644 )          2,941            23.3 %           (2.1 )%         (2.8 )%

Income from
continuing operations
before income taxes
and discontinued
operations                     7,386           21,595          (14,209 )         (65.8 )%           1.6 %           4.7 %
Income tax expense             2,998            8,917           (5,919 )         (66.4 )%           0.7 %           1.9 %

Income from
continuing operations          4,388           12,678           (8,290 )         (65.4 )%           0.9 %           2.8 %
Income from
discontinued
. . .
  Add MDTH to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDTH - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.